DAPD: Phase I/II

VIRS researchers reported that in a 14 day, open-label trial of DAPD

Read the full 121 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE